Idiotypic vaccination in B-cell malignancies

Molecular Medicine Today

Volumn 3, Issue 10, 1997, Pages 435-441

  Bianchi, Alberto ^a   Massaia, Massimo ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; AMINO ACID; ANTIGEN; ANTIIDIOTYPIC ANTIBODY; ANTINEOPLASTIC AGENT; B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA; DNA VACCINE; FREUND ADJUVANT; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HAPTEN; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN IDIOTYPE; INTERLEUKIN 2; KEYHOLE LIMPET HEMOCYANIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MURAMYL DIPEPTIDE DERIVATIVE; POLYMER; T LYMPHOCYTE RECEPTOR; THYROGLOBULIN; TUMOR ANTIGEN; VACCINE;

ANTIGEN PRESENTING CELL; B CELL LYMPHOMA; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNITY; IMMUNOGENICITY; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MULTIPLE MYELOMA; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VACCINATION;

EID: 0030809790     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)89745-6     Document Type: Review

References (33)

1. Bogen, B. (1993) Processing and presentation of immunoglobulinun idiotypes to T cells, Immunologist 1, 121-125
2. Massaia, M. et al. (1995) Dysregulated Fas and bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients, Blood 85, 3679-3687
3. Lynch, R.G. et al. (1972) Myeloma proteins as tumor-specific transplantation antigens, Proc. Natl. Acad. Sci. U. S. A. 69, 1540-1544
4. Hannestad, K., Kao, M.S. and Eisen, H.N. (1972) Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system, Proc. Natl. Acad. Sci. U. S. A. 69, 2295-2300
5. Kwak, L.W. et al. (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors, New Engl. J. Med. 327, 1209-1215
6. Hsu, F.J. et al. (1997) Tumor-specific idiotype vaccines in the treatment of patients with B cell lymphoma. Long-term results of a clinical trial, Blood 89, 3129-3135
7. Nelson, E.L. et al. (1996) Tumor-specific, cytotic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma, Blood 88, 580-589
8. Massaia, M. and Pileri, A. (1995) T cells in multiple myeloma: is this a reliable population to count on as antitumor effector cells? Leuk. Lymphoma 17, 63-70
9. Munshi, N.C. (1997) Immunoregulatory mechanisms in multiple myeloma, Hematol. Oncol. Clin. North Am. 11, 51-69
10. Bergenbrant, S. et al. (1996) Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients, Br. J. Haematol. 92, 840-846
11. Audibert, F.M. and Use, D.L. (1993) Adjuvants: current status, clinical perspectives and future prospects, Immunol. Today 14, 281-284
12. Musiani, P. et al. (1997) Cytokines, tumor-cell death and immunogenicity: a question of choice, Immunol. Today 18, 32-36
13. Tarr, P.E. (1996) Granulocyte-macrophage colony-stimulating factor and the imummme system, Med. Oncol. 13, 133-140
14. Levitsky, H.I. et al. (1996) Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity, J. Immunol. 156, 3858-3865
15. Kwak, L.W., Young, H.A., Pennington, R.W. and Weeks, S.D. (1996) Vaccination with syngemeic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response, Proc. Natl. Acad. Sci. U. S. A. 93, 10972-10977
16. Tao, M.H. and Levy, R. (1993) Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma, Nature 362, 755-758
17. Chen, T.T., Tao, M.H. and Levy, R. (1994) Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor, J. Immunol. 153, 4775-4787
18. Sternas, L. et al. (1996) Early results of a clinical trial of therapeutic vaccination with Ig idiotype antigen for de novo follicular lymphoma, Blood 88 (Suppl.), 672a
19. Yi, Q. et al. (1995) Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies, Blood, 86, 3043-3049
20. Osterborg, A. et al. (1996) Idiotype immunization in combination with GMCSF of myeloma patients induced a CD8 T cell response and tumor regression, Blood 88 (Suppl.), 585a
21. Borrione, P. et al. (1996) Subcutaneous administration of idiotype/KLH conjugates and rIL-2 or rGM-CSF as active specific immunotherapy in human myeloma, Haematologica 81 (Suppl. 5), 144
22. Stevenson, F.K. et al. (1995) Idiotypic DNA vaccines against B-cell lymphoma, Immunol. Rev. 145, 211-228
23. Brissinck, J. et al. (1996) Idiotypic plasmid vaccination for follicular lymphoma, Education Sessions of the Second European Haematology Association (EHA), 1-6
24. Syrengelas, A.D., Chen, T.T. and Levy, R. (1996) DNA immunization induces protective immunity against B-cell lymphoma, Nat. Med. 2, 1038-1041
25. Hakim, I., Levy, S. and Levy, R. (1996) A nime-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines, J. Immunol. 157, 5503-5511
26. Girolomoni, G. and Ricciardi-Castagnoli, P. (1997) Dendritic cells hold promise for immunotherapy, Immunol. Today 18, 102-104
27. Flamand, V. et al. (1994) Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo, Eur. J. Immunol. 24, 605-610
28. Hsu, F.J. et al. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells, Nat. Med. 2, 52-58
29. Reichardt, V. et al. (1996) Idiotypic vaccination using dendritic cells for multiple myeloma patients after autologous peripheral blood stem cell transplantation, Blood 88 (Suppl.), 481a
30. Condon, C. et al. (1996) DNA-based immunization by in vivo transfection of dendritic cells, Nat. Med. 2, 1122-1128
31. + T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma, Eur. J. Immunol. 26, 2671-2679
32. Kwak, L.W., Pennington, R. and Longo, D.L. (1996) Active immunization of murine allogeneic bone marrow transplant donors with B-cell tumor-derived idiotype: a strategy for enhancing the specific antitumor effect of marrow grafts, Blood 87, 3053-3060
33. Kwak, L.W. et al. (1995) Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor, Lancet 345, 1016-1020